The predictive power of plasma proteomic profiles for future dementia onset in adults without dementia.
ProductLife enhances drug development with IntiQuan acquisition
IntiQuan enhances PLG’s portfolio with advanced dose-response evaluations and proactive safety assessments. Credit: IM Imagery/Shutterstock. ProductLife Group (PLG) has announced the acquisition of IntiQuan, a